{"schema_version":"secwatch.filing_event.v1","accession":"0001651308-24-000154","form_type":"8-K","ticker":"ONC","cik":"0001651308","company_name":"BeOne Medicines Ltd.","filed_at":"2024-11-14T23:59:59+00:00","discovered_at":"2026-05-14T18:03:09.111382+00:00","generated_at":"2026-05-30T00:29:58.022746+00:00","sec_items":["8.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.3,"calibrated_materiality_score":0.3,"confidence":"high","headline":"BeiGene plans to change name to BeOne Medicines Ltd.; ticker to become ONC","bullets":["Name change to BeOne Medicines Ltd. subject to shareholder approval at a future meeting.","Nasdaq ticker symbol will change to 'ONC' upon completion of the name change.","Rebranding reflects commitment to develop innovative cancer medicines through global partnerships.","Shareholders urged to read definitive proxy statement when filed with the SEC."],"urls":{"canonical":"https://secwatch.observer/filing/0001651308-24-000154","json":"https://secwatch.observer/filing/0001651308-24-000154.json","markdown":"https://secwatch.observer/filing/0001651308-24-000154.md","text":"https://secwatch.observer/filing/0001651308-24-000154.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1651308/000165130824000154/0001651308-24-000154-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1651308/000165130824000154/bgne-20241114.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-30T00:29:58.022746+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}